Compounds containing derivatives of isoxazolina, an MPS inhibitor； pharmacological components of these compounds； pharmacological toolkits； compounds used in the treatment of diseases such as skeletal arthritis, rheumatoid arthritis, youth arthritis, psychosis, lupus erythematosus, etc.
CALDERWOOD DAVID J,BRIENLINGER ERIC C.,SWANN STEVEN L,MUKHERJEE SUBHENDU,CHITTY VENKATA SRIKANTH,THUNUGUNTLA SIVA SANJEEVA RAO,HOSAHALLI SUBRAMANYAH SEETHARAMA SHASTRY
申请号：
CL2013003125
公开号：
CL2013003125A1
申请日:
2013.10.29
申请国别(地区):
CL
年份:
2014
代理人:
摘要：
The present invention provides compound of Formula (I) biologically active metabolites, pro-drugs, isomers, stereoisomers, solvates, hydrates and pharmaceutically acceptable salts thereof wherein the variables are defined herein. The compounds of the invention are useful for treating immunological conditions.COMPUESTOS DERIVADOS DE ISOXAZOLINAS INHIBIDORES MPS； COMPOSICION FARMACEUTICA QUE LOS COMPRENDE； KIT FARMACEUTICO； Y USO EN EL TRATAMIENTO DE UNA ENFERMEDAD TALES COMO OSTEOARTRITIS, ARTRITIS REUMATOIDE, ARTRITIS JUVENIL, ARTRITIS PSORIASICA, LUPUS ERITEMATOSO SISTEMICO, ENTRE OTRAS.
